Global Embolotherapy Market - 2024-2031

Global Embolotherapy Market - 2024-2031

Global embolotherapy market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Embolotherapy is a type of endovascular treatment aiming to block abnormal blood vessels to manage hurt, blood vessel malformations, revascularize organs, and scale back tumors. This blockage of blood vessels is called vascular occlusion.

Stainless steel coils, absorbable gelatin pledges and powder, polyvinyl alcohol foam, ethanol, and glue are the main embolic agents used. In the arterial system, both of these agents operate at various levels; for example, coils are similar to surgical ligation and block medium to small arteries, while liquid agents and particles of smaller diameter block at the level of the arteriolar or capillary bed.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic diseases

The increasing prevalence of several chronic diseases, including cancer, strokes are expected to drive the global Embolotherapy market during the forecasting period.

For instance, according to the report by the American Cancer Society in 2024, it is estimated that about 41,630 new cases will be diagnosed and about 29,840 people will die of these cancers. Additionally, the percentage of people with liver cancer has steadily been increasing in the last decade.

For people whose cancer is found before it's spread outside the liver, the 5-year survival rate is about 31%. If liver cancer has spread to other parts of the body, the 5-year survival rate is about 3%.

On the other hand, Strokes remain the fifth-leading cause of death in the United States. Stroke strikes every five minutes. 100,000 people have strokes each year. Thus, the above factors are expected to increase the demand for embolotherapy and are about to drive the market growth.

Stringent regulatory frameworks for product commercialization

Rigorous clinical trials and regulatory hurdles can significantly delay the market entry of new embolization devices. Stringent regulations can lead to higher costs associated with product development and clinical trials.

For more details on this report – Request for Sample

Segment Analysis

The global embolotherapy market is segmented based on product, disease, end-user and region.

Microspheres segment is expected to dominate the market growth

Microspheres vary in size and composition, allowing them to target a wide range of blood arteries and be employed in a variety of embolization techniques. Because of their versatility, they are an effective treatment for a wide range of disorders. The size and distribution of microspheres can be accurately regulated during embolization. This enables targeted treatment of specific locations while reducing the possibility of unintentional occlusion of healthy veins.

Microspheres effectively prevent blood flow by adhering to the geometry of the target vessel. This provides a more thorough blockage than certain other embolic agents. Thus, the above factors are expected to hold the dominant position in the market share.

Geographical Analysis

Asia-Pacific is expected to hold a significant position in the embolotherapy market share

Asia-Pacific region is expected to hold a significant position in the market share. Chronic diseases such as cancer, peripheral vascular disease, and neurological problems are becoming increasingly prevalent in Asia Pacific countries. These conditions are ideal candidates for embolization procedures, increasing demand for embolization devices and procedures in the region. Governments and commercial healthcare providers in the Asia Pacific are increasing their investments in healthcare infrastructure and modern medical technologies.

Asia Pacific hosts 50 percent of the world's new cancer cases each year, and deaths caused by cancer in Asia are expected to increase by 36 percent by 2030. According to the World Economic Forum in 2024, it is estimated that Asia accounts for 45% of all global breast cancer cases and 58% of cervical cancer deaths worldwide. Thus, the above factors are expected to hold the region in the dominant position.

COVID-19 Impact Analysis

Due to the covid-19 pandemic outbreak, the global embolotherapy market was down in the production and sale segments. The outbreak led to the shutdown of all manufacturing firms, except for masks, sanitizers and ventilators. Hence, the products were manufactured less compared to previous years during the outbreak. Hospitals were overwhelmed with COVID-19 patients, imposing a strain on resources and reducing capacity for additional therapies.

Market Segmentation

By Product
• Microspheres
• Embolic coils
• Microcatheters
• Guidewires
• Others

By Disease
• Oncology
• Aneurysm
• Peripheral Vascular Diseases
• Others

By End-User
• Hospitals
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Medtronic Plc, Terumo Medical Corporation, GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Boston Scientific Corporation, Sirtex Medical Limited, Stryker Corporation, Cook Medical and Merit Medical Systems Inc. among others.

Key Developments
• On October 13, 2023, Merit Medical Systems this week announced the launch of its expanded Maestro microcatheter product line. The Maestro product line features embolotherapy devices, which include Embosphere Microspheres.
• On December 11, 2023, Terumo Medical Corporation launched its new AZUR HydroPack Peripheral Coil System in the United States. The AZUR HydroPack Coil System is a soft, universal-shaped platinum and hydrogel coil designed to find and fill empty space within the vessel.

Why Purchase the Report??
• To visualize the global embolotherapy market segmentation based on product, disease and end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of embolotherapy market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global embolotherapy market report would provide approximately 53 tables, 47 figures and 176 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies